Galecto is a privately held Denmark-based biopharmaceutical company developing small molecules for the treatment of severe diseases; including fibrosis, cancer, and inflammation.
Galecto
![Galecto](http://baycitycapital.com/wp-content/uploads/2020/10/galecto-194-146.jpg)
Galecto is a privately held Denmark-based biopharmaceutical company developing small molecules for the treatment of severe diseases; including fibrosis, cancer, and inflammation.